A Registry-Based Clinical Trial of Pimozide in Patients With Neuromuscular Junction Transmission Dysfunction Due to ALS A Registry-Based Clinical Trial of Pimozide in Patients With Neuromuscular Junction Transmission Dys ...
A Registry-Based Randomized-Controlled, Double-Blinded Clinical Trial of Pimozide in Patients With Neuromuscular Junction Transmission Dysfunction Due to Amyotrophic Lateral Sclerosis A Registry-Based Randomized-Controlled, Double-Blinded Clinical Trial of Pimozide in Patients With N ...
Amyotrophic Lateral Sclerosis (ALS)
Drug: Pimozide 2 mg per day;Drug: Pimozide 4 mg per day;Drug: Placebo (Lactose tablet)